Lipid profile Nutritional, Metabolic, Endocrine
Conditions
Interventions
A randomized, placebo-controlled, prospective clinical trial was conducted at the Institute of Medical Research (MRI), Colombo, Sri Lanka. Participants were recruited from a local advertisement displa
Sponsors
Medical Research Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy volunteers aged 25-60 years 2. Total cholesterol level =250 mg/dl 3. Triglyceride level =300 mg/dl 4. Not on any form of medication or on nutritional supplementation
Exclusion criteria
Exclusion criteria: 1. Total cholesterol level =250 mg/dl 2. Triglyceride level =300 mg/dl 3. On any form of medication or nutritional supplementation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Lipid profile (consisting of total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride concentrations) measured at baseline and after 4 and 8 weeks. Lipid profiles were done after 10 hours of mandatory fasting and FBS was done after 8 hours fast. 1.1. Total cholesterol, HDL-cholesterol and triglyceride concentrations measured in serum by a Roch/Hitachi Modular P Chemistry Analyzer (Mod P) 1.2. The cholesterol assay used the cholesterol oxidase/peroxidase (CHOD/POD) method 1.3. HDL cholesterol was measured by a direct non-precipitating method using polyethylene glycol-coupled cholesteryl esterase (PEG-modified enzyme) and cholesterol oxidase 1.4. Triglycerides were analyzed using the glycerokinase/glycerophosphate oxidase method after initial hydrolysis with lipoprotein lipase. LDL cholesterol was calculated using the Friedewald formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood sugar (FBS) and HbA1c measured using Abbott’s Diabetes Care FreeStyle Libre at baseline, after 4 weeks and 8 weeks | — |
Countries
Sri Lanka
Outcome results
None listed